new_0222_0299|ALGS|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment
new_0222_0299|ALGS|Long Name|1|1|Aligos Therapeutics Inc Total Current Assets (Quarterly) (USD)|Aligos Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Aligos Therapeutics Inc Inventories (Quarterly) (USD)|Aligos Therapeutics Inc Net PP&E (Quarterly) (USD)|Aligos Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Aligos Therapeutics Inc Total Liabilities (Quarterly) (USD)|Aligos Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Aligos Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Aligos Therapeutics Inc Total Deposits (Quarterly) (USD)|Aligos Therapeutics Inc Book Value (Quarterly) (USD)|Aligos Therapeutics Inc Retained Earnings (Quarterly) (USD)|Aligos Therapeutics Inc Treasury Stock (Quarterly) (USD)|Aligos Therapeutics Inc EV to Revenues|Aligos Therapeutics Inc EV to Earnings|Aligos Therapeutics Inc EV to Free Cash Flow|Aligos Therapeutics Inc EV to Assets (Quarterly)|Aligos Therapeutics Inc PS Ratio|Aligos Therapeutics Inc PE Ratio|Aligos Therapeutics Inc Price to Book Value|Aligos Therapeutics Inc PEG Ratio|Aligos Therapeutics Inc Debt to Equity Ratio|Aligos Therapeutics Inc Dividend Yield|Aligos Therapeutics Inc Shareholder Yield (TTM)|Aligos Therapeutics Inc Percent of Shares Outstanding Short|Aligos Therapeutics Inc Total Receivables (Quarterly) (USD)|Aligos Therapeutics Inc Total Payables (Quarterly) (USD)|Aligos Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Aligos Therapeutics Inc Return on Invested Capital|Aligos Therapeutics Inc Quality Ratio Score|Aligos Therapeutics Inc Momentum Score|Aligos Therapeutics Inc Beta (1Y)|Aligos Therapeutics Inc Sustainable Growth Rate (TTM)|Aligos Therapeutics Inc Institutional Investor Ownership Percentage|Aligos Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Aligos Therapeutics Inc Total Employees (Annual)|Aligos Therapeutics Inc EPS Diluted (Quarterly) (USD)|Aligos Therapeutics Inc SG&A Expense (Quarterly) (USD)|Aligos Therapeutics Inc Shares Outstanding|Aligos Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Aligos Therapeutics Inc Ordinary Shares Number (Quarterly)|Aligos Therapeutics Inc Payout Ratio|Aligos Therapeutics Inc Quick Ratio (Quarterly)|Aligos Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Aligos Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Aligos Therapeutics Inc Effective Tax Rate (TTM)|Aligos Therapeutics Inc Return on Equity|Aligos Therapeutics Inc Net Income (TTM) (USD)|Aligos Therapeutics Inc Revenue (TTM) (USD)|Aligos Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Aligos Therapeutics Inc Revenue (Quarterly) (USD)|Aligos Therapeutics Inc Gross Profit (Quarterly) (USD)|Aligos Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Aligos Therapeutics Inc Net Income (Quarterly) (USD)|Aligos Therapeutics Inc Net Interest Income (Quarterly) (USD)|Aligos Therapeutics Inc Price (USD)|Aligos Therapeutics Inc Total Return Price (USD)|Aligos Therapeutics Inc Enterprise Value (USD)|Aligos Therapeutics Inc 30-Day Average Daily Volume|Aligos Therapeutics Inc 1 Year Price Returns (Daily)|Aligos Therapeutics Inc Short Interest|Aligos Therapeutics Inc PE Ratio (Forward)|Aligos Therapeutics Inc PE Ratio (Forward 1y)|Aligos Therapeutics Inc PS Ratio (Forward)|Aligos Therapeutics Inc PS Ratio (Forward 1y)|Aligos Therapeutics Inc Quarterly EPS Estimates (USD)|Aligos Therapeutics Inc Quarterly Revenue Estimates (USD)|Aligos Therapeutics Inc Quarterly EPS Surprise|Aligos Therapeutics Inc Quarterly Revenue Surprise|Aligos Therapeutics Inc Quarterly Actual EPS (USD)|Aligos Therapeutics Inc Quarterly Actual Revenue (USD)|Aligos Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Aligos Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Aligos Therapeutics Inc Price Target (USD)|Aligos Therapeutics Inc Consensus Recommendation|Aligos Therapeutics Inc Price Target Num Estimates|Aligos Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Aligos Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Aligos Therapeutics Inc Research and Development Expense (Quarterly) (USD)|Aligos Therapeutics Inc Reconciled Depreciation (Quarterly) (USD)|Aligos Therapeutics Inc Non-Operating Interest Expense (Quarterly) (USD)|Aligos Therapeutics Inc Land and Improvements (Quarterly) (USD)|Aligos Therapeutics Inc Buildings and Improvements (Quarterly) (USD)|Aligos Therapeutics Inc Other Properties (Quarterly) (USD)|Aligos Therapeutics Inc Machine, Furniture & Equipment (Quarterly) (USD)
new_0222_0299|ALGS|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric
new_0222_0299|ALGS||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0299|ALGS||5|5|106.5|106.5|0|106.5|0|106.5|106.5|106.5|0|106.5|106.5|0|0|0|1.44755244755|91.5|0|0|1.44755244755|0|91.5|1.44970414201|0|15.2666666667|0|106.5|106.5|0|0|31|30.6666666667|0|30.4444444444|91.375|91.4|91.375|91.375|29.8461538462|91.3333333333|106.5|0|91.5|91.375|91.25|91.4|0|91.4|0|0|91.5|0|91.375|91.375|91.375|1.44970414201|1.44970414201|1.44970414201|1.4498381877|1.43023255814|15.2666666667|0|0|1.45019920319|0|91.25|91.3333333333|91|0|91.25|91.25|23.15|28.9375|24.4210526316|9.4693877551|24.4210526316|28.9375|30.8666666667|91.375|91.375|0|0|0|106.5|106.5
new_0222_0299|ALGS||6|6|6|6|0|6|0|6|6|6|0|6|6|0|0|0|286|2|0|0|286|0|2|338|0|30|0|6|6|0|0|2|3|0|9|8|5|8|8|13|6|6|0|2|8|4|5|0|5|0|0|2|0|8|8|8|338|338|338|309|86|30|0|0|251|0|8|9|3|0|4|4|20|16|19|49|19|16|15|8|8|0|0|0|6|6
new_0222_0299|ALGS||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0299|ALGS|201909|201909|201909||||||||||||||||||||||||||||||||||21.9313||-0.6407|2.775||||||-0.6407|||||||||-14.051|-14.051|0.345||||||||||||||||||||||||11.729|0.626|||||
new_0222_0299|ALGS|201912|201912|201912|120.226|117.663||16.087||211.411|13.818|197.593||-64.891|-66.197|||||||||||||||3.767|0|||||||21.9313||-0.8291|3.463|||36.8902|||-0.8291|||||||||-18.099|-18.184|0.556||||||||||||||||||||||||14.973|0.644||||10.774|1.611
new_0222_0299|ALGS|202003|202003|202003||||||||||||||||||||||||||||||||||21.9313||-0.9133|3.419||-0.405||||-0.9133|||||||||-20.029|-20.029|0.468||||||||||||||||||||||||17.302|0.46|||||
new_0222_0299|ALGS|202006|202006|202006|132.229|128.897||16.212||26.718|15.364|11.354||121.958|-107.023|||||||||||||||3.296|0.002|||||||21.9313|67|-0.9483|4.095||0|36.8902|||-0.9483||-0.0356||-73.061|||||-20.856|-20.797|0.374||||||||||||||||||||||||17.176|1.097||||11.783|1.669
new_0222_0299|ALGS|202009|202009|202009|73.693|70.064||15.646||228.851|19.984|208.867||-136.668|-140.32|||||||||||||||7.682|0|||||||36.8902|73|-0.9026|4.225||0|36.8902|||-0.9026|0|-0.0282||-92.307|||||-33.297|-33.297|0.234||||||||||||0|||-0.5593|0||||||||17.332|0.885||||11.801|1.692
new_0222_0299|ALGS|202010|202009|202009||||||||||||||||||||||0||5.2978||||||||||||||36.8902|||||||||||||||||14.94|14.94|481.0756|||1954374||||||||||||||||||||||||
new_0222_0299|ALGS|202011|202009|202009||||||||||||||||||||||0||3.4653|||||||||19.4208|||||38.1179|||||||||||||||||18.71|18.71|643.1219|187321.6||1320905|||||||||||0|0|30.5|1.5|4|-3.6444|-3.744|||||||
new_0222_0299|ALGS|202012|202012|202012|250.017|243.513||14.908||45.263|30.274|14.989||220.039|-174.74||||-10.0705||||4.5999|||0||5.3504||3.313|0.004|||||||36.6062|74|-1.09|6.205|36.6062|0.405|36.6062|||-1.09|-155.542|-0.1476||-108.543|||||-34.201|-34.42||27.65|27.65|768.6484|260801.6667||1958588|||253.1669||-0.8976|0|-21.4309||-1.09|0|0||31.5|1.5|4|-3.6444||28.081|0.883||||11.734|1.697
new_0222_0299|ALGS|202101|202012|202012|||||||||||||||-10.3199||||4.6864|||0||3.5773|||||||||||||||||||||||||||||||28.17|28.17|787.6837|207326.0333||1309518|||257.9281|||||||||0|34.5|1.5|4|||||||||
new_0222_0299|ALGS|202102|202012|202012|||||||||||||||-10.5932||||4.7813|||0||4.101|||||||||||||||||||||||||||||||28.74|28.74|808.5492|80934.5||1501229|||263.1471|||||||||||1.5||||||||||
new_0222_0299|ALGS|202103|202103|202103|219.826|213.415||14.526||39.32|25.231|14.089||195.22|-202.414||||-7.6928|2.7887|||4.4435||0|0||4.0591||2.81|0.004|||||||37.4343|69|-0.74|5.781|38.1472|0|38.1472||8.4584|-0.74||-0.1768||-116.188|||0.91||-27.629|-27.674|0.105|22.74|22.74|654.0523|59909.5333||1548431|||216.9753||-0.9405|0|21.3184||-0.74|0.91||0|35.75|1.5|4|-3.862|-3.8426|22.869|0.873||||12.098|1.733
new_0222_0299|ALGS|202104|202103|202103|||||||||||||||-9.0301||||5.0259|||0||4.2654||||||||||||||38.1478|||||||||||||||||25.72|25.72|767.7464|63420.6||1627147|||245.4131||||||||0|0|34.3333|1.3333|3|||||||||
new_0222_0299|ALGS|202105|202103|202103|||||||||||||||-10.0012||||5.4489|||0||4.105||||||||||||||38.1537|||||||||||||||||27.88|27.88|850.3102|77564.9333||1566196|||266.0643||||||||0.9067|0|36.75|1.5|4|-3.2973|-3.5168|||||||
new_0222_0299|ALGS|202106|202106|202106|196.642|190.653||13.753||42.992|30.098|12.894||168.884|-232.232||||-6.5392|2.7755|||4.6109||0|0||4.4728||1.593|0.004|||||||37.619|86|-0.79|6.556|38.2001|0|38.2001||6.3344|-0.79||-0.2338||-125.209|||1.545||-29.79|-29.818|0.072|20.385|20.385|588.056|166961.1||1708596|||194.7746||-0.8117|0|2.6722||-0.79|1.545|||36.75|1.5|4|||24.554|0.925||||12.015|1.756
new_0222_0299|ALGS|202107|202106|202106|||||||||||||||-4.7744||||3.6712|||0||4.3347|||||||||95.7986|||||42.5537|||||||||||||||||14.57|14.57|429.3544|386812.3||1844589|||155.0794||||||||||36.75|1.5|4|||||||||
new_0222_0299|ALGS|202108|202106|202106|||||||||||||||-5.9584||||4.3017|||0||4.223|||||||||95.0119|||||42.6088|||||||||||||||||17.05|17.05|535.827|189153.1667||1799376|||181.7109||||||||2.4775|0|35|1.5|4|-3.1558|-3.2816|||||||
new_0222_0299|ALGS|202109|202109|202109|248.67|242.185||13.158||46.057|34.78|11.277||217.011|-265.358||||-4.2517|1.5917|||3.0455||0|0||4.4608||2.601|0.004|||||||42.4|86|-0.78|6.473|42.6118|0|42.6118||6.9633|-0.78|-78.584|-0.3354||-125.036|||1.537||-32.998|-33.124|0.02|15.51|15.51|418.724|251853.8667||1900846|||165.3099||-0.8235|0|5.2846||-0.78|1.537|2.482|0|33.8|1.4|5|-3.1618|-3.2862|28.132|0.967||||12.139|1.765
new_0222_0299|ALGS|202110|202109|202109|||||||||||||||-4.4335||||3.128|||0||4.6745|||||||1.9573||||||||||||||||||||||||15.93|15.93|436.621|171788.2|7.7808|1991872|||169.7864|||||||||||1.4|||-3.2862|||||||
new_0222_0299|ALGS|202111|202109|202109|||||||||||||||-4.1702||||3.0085|||0||4.9851||||||4|1.3607|||||||42.6162|||||||||||||||||15.32|15.32|410.6952|139355|-18.1187|2124475|||163.3507||||||||3.9968|0|33.8|1.4|5|-3.1539|-3.4894|||||||
new_0222_0299|ALGS|202112|202112|202112|||||||||||||||-2.6773||||2.331|||0||5.2997||||||3|0.1472||||||||||||||||||||||||11.87|11.87|263.6693|205612.6667|-57.0705|2258519|||127.6311||-0.8335|0|||||3.9968|0|30.8|1.4|5|-3.1539||||||||
new_0222_0299|ALGS|202201|202112|202112|||||||||||||||1.0788||||0.6264|||0||4.7633||||||2|3.3104||||||||||||||||||||||||3.19|3.19|-106.2393|681731.2|-88.6759|2029943|||||||||||0|0|19.2|2|5|-3.3819|-3.3576|||||||
new_0222_0299|ALGS|202202|202112|202112|||||||||||||||1.412||||0.4752|||0|||||||||||||||||||||||||||||||||2.42|2.42|-139.0538|698757.2667|-91.735||||||||||||0|0|18.2|2|5|-3.3469|-3.2451|||||||
new_0222_0299|ALGS|202203|202203|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.795|0||||||||||||||||||
new_0222_0299|ALGS|202206|202206|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.8|0||||||||||||||||||
new_0222_0299|ALGS|202209|202209|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.765|0||||||||||||||||||
new_0222_0299|ALGS|202212|202212|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.8|0||||||||||||||||||